CD8A and multiple sclerosis: Furthermore, the suppressive activity of CD8+ Treg in vivo has been shown to be important in regulating normal immune function and preventing inflammatory disease in humans, including inflammatory bowel disease, autoimmune diabetes, multiple sclerosis, and GVHD (167–169).